ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,088,834 | -18.8% | 199,786 | 0.0% | 0.07% | -23.2% |
| Q2 2023 | $1,340,564 | -25.1% | 199,786 | -1.4% | 0.10% | -31.2% |
| Q1 2023 | $1,789,938 | +28.9% | 202,711 | +11.6% | 0.14% | +2.2% |
| Q4 2022 | $1,388,272 | +7.1% | 181,711 | -0.2% | 0.14% | 0.0% |
| Q3 2022 | $1,296,000 | -12.0% | 182,161 | 0.0% | 0.14% | -2.9% |
| Q2 2022 | $1,473,000 | -41.6% | 182,161 | +0.2% | 0.14% | -34.4% |
| Q1 2022 | $2,522,000 | -49.4% | 181,711 | +2.4% | 0.21% | -49.4% |
| Q4 2021 | $4,981,000 | -18.4% | 177,536 | -1.1% | 0.42% | -39.2% |
| Q3 2021 | $6,102,000 | -16.8% | 179,536 | 0.0% | 0.69% | -21.8% |
| Q2 2021 | $7,335,000 | -2.3% | 179,536 | -3.8% | 0.88% | -26.6% |
| Q1 2021 | $7,509,000 | -40.1% | 186,536 | -12.0% | 1.20% | -54.1% |
| Q4 2020 | $12,531,000 | -4.3% | 211,936 | -21.3% | 2.62% | -18.6% |
| Q3 2020 | $13,090,000 | -43.5% | 269,186 | -43.8% | 3.22% | -51.9% |
| Q2 2020 | $23,173,000 | +55.3% | 478,979 | -10.8% | 6.69% | +31.2% |
| Q1 2020 | $14,920,000 | +275.3% | 537,095 | +304.1% | 5.10% | +154.1% |
| Q4 2019 | $3,976,000 | – | 132,916 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |